A storied history of firsts
Stony Brook has long been a pioneer and an innovator on the research front. Many things we now take for granted were game changers when they were first discovered or developed in our labs. For example, our researchers developed the technology for the MRI, PET imaging and virtual colonoscopy. They discovered the etiologic agent for Lyme disease. And they developed the first FDA-approved antiplatelet and anti-integrin receptor drug. These are but a few of the ways Stony Brook research endeavors have had a profoundly lasting and positive impact on global health.
A commitment to the future
Because faculty within our clinical departments also serve as investigators for clinical research studies, Stony Brook Medicine can bring new ideas in treatments and technologies to patients more quickly. Our state-of-the-art Medical and Research Translation (MART) building is a testament to our commitment to the future of healthcare. Home to the Stony Brook Cancer Center, the MART’s research also focuses on today’s top health issues, including infectious diseases, neurosciences and advanced medical imaging.
Our advanced research infrastructure also includes a cyclotron, an animal biosafety level 3 facility, a Center for Understanding Biology using Imaging Technology (CUBIT) and the Long Island Network for Clinical and Translational Science (LINCATS).